| Polycystic ovary syndrome RJ Norman, D Dewailly, RS Legro, TE Hickey The Lancet 370 (9588), 685-697, 2007 | 2263 | 2007 |
| Progesterone receptor modulates ERα action in breast cancer H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ... Nature 523 (7560), 313-317, 2015 | 884 | 2015 |
| Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. WD Tilley, G Buchanan, TE Hickey, JM Bentel Clinical cancer research: an official journal of the American Association …, 1996 | 552 | 1996 |
| Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? TE Hickey, JLL Robinson, JS Carroll, WD Tilley Molecular endocrinology 26 (8), 1252-1267, 2012 | 356 | 2012 |
| Androgens induce divergent proliferative responses in human breast cancer cell lines SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ... The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995 | 319 | 1995 |
| Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation RB Gilchrist, LJ Ritter, S Myllymaa, N Kaivo-Oja, RA Dragovic, TE Hickey, ... Journal of cell science 119 (18), 3811-3821, 2006 | 296 | 2006 |
| The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome T Hickey, A Chandy, RJ Norman The Journal of Clinical Endocrinology & Metabolism 87 (1), 161-165, 2002 | 293 | 2002 |
| The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ... Nature medicine 27 (2), 310-320, 2021 | 270 | 2021 |
| Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ... Cell cycle 11 (14), 2756-2761, 2012 | 270 | 2012 |
| PCOS Forum: research in polycystic ovary syndrome today and tomorrow R Pasquali, E Stener‐Victorin, BO Yildiz, AJ Duleba, K Hoeger, H Mason, ... Clinical endocrinology 74 (4), 424-433, 2011 | 265 | 2011 |
| FOXA1: master of steroid receptor function in cancer MA Augello, TE Hickey, KE Knudsen The EMBO journal 30 (19), 3885-3894, 2011 | 228 | 2011 |
| Regulators of genetic risk of breast cancer identified by integrative network analysis MAA Castro, I de Santiago, TM Campbell, C Vaughn, TE Hickey, E Ross, ... Nature genetics 48 (1), 12-21, 2016 | 216 | 2016 |
| Complexities of androgen receptor signalling in breast cancer KM McNamara, NL Moore, TE Hickey, H Sasano, WD Tilley Endocrine-related cancer 21 (4), T161-T181, 2014 | 181 | 2014 |
| Deciphering the divergent roles of progestogens in breast cancer JS Carroll, TE Hickey, GA Tarulli, M Williams, WD Tilley Nature Reviews Cancer 17 (1), 54-64, 2017 | 160 | 2017 |
| Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer H Singhal, ME Greene, G Tarulli, AL Zarnke, RJ Bourgo, M Laine, ... Science Advances 2 (6), e1501924, 2016 | 156 | 2016 |
| Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells TE Hickey, DL Marrocco, F Amato, LJ Ritter, RJ Norman, RB Gilchrist, ... Biology of Reproduction 73 (4), 825-832, 2005 | 154 | 2005 |
| A patient‐derived explant (PDE) model of hormone‐dependent cancer MM Centenera, TE Hickey, S Jindal, NK Ryan, P Ravindranathan, ... Molecular oncology 12 (9), 1608-1622, 2018 | 147 | 2018 |
| Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer S Paltoglou, R Das, SL Townley, TE Hickey, GA Tarulli, I Coutinho, ... Cancer research 77 (13), 3417-3430, 2017 | 135 | 2017 |
| Expression of androgen receptor splice variants in clinical breast cancers TE Hickey, CM Irvine, H Dvinge, GA Tarulli, AR Hanson, NK Ryan, ... Oncotarget 6 (42), 44728, 2015 | 115 | 2015 |
| Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype JLL Robinson, TE Hickey, AY Warren, SL Vowler, T Carroll, AD Lamb, ... Oncogene 33 (50), 5666-5674, 2014 | 108 | 2014 |
